Generic depression patch tested against brand in small study
Knowledge-focused
Completed
This study tested a generic version of the selegiline skin patch (6 mg/24 hours) against the brand-name EMSAM in 12 healthy adults. The goal was to see if the generic patch delivers the same amount of medicine into the body and to check for skin irritation. This was a pilot study…
Sponsor: Corium Innovations, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 10:27 UTC